Microbot Medical
MBOT
31 hedge funds and large institutions have $3.25M invested in Microbot Medical in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 30 → 31 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.52% less ownership
Funds ownership: 14.76% → 14.24% (-0.52%)
1% less capital invested
Capital invested by funds: $3.27M → $3.25M (-$19K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$29.2K |
| 2 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
+$11.7K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$3.85K |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$1.09K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$567 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$67K |
| 2 |
JP Morgan Chase
New York
|
-$45K |
| 3 |
Renaissance Technologies
New York
|
-$31.2K |
| 4 |
Morgan Stanley
New York
|
-$11.4K |
| 5 |
BlackRock
New York
|
-$3.09K |
MBOT Hedge Fund Activity: Q3 2019 in Review
31 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2019, worth a combined $3.25M — down 0.58% from $3.27M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBOT positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Bank of Montreal, adding an estimated $29.2K. The largest seller was Millennium Management, exiting entirely with an estimated $67K sold.
- 31 institutional investors held Microbot Medical (MBOT) as of Q3 2019, up from 30 in Q2 2019.
- Funds reported $3.25M of Microbot Medical stock for Q3 2019, down 0.58% quarter-over-quarter.
- 6 funds opened new Microbot Medical positions in Q3 2019 and 5 closed out, a net change of +1 holder.
- The largest Microbot Medical buyer in Q3 2019 was Bank of Montreal, an estimated $29.2K added.
- The largest Microbot Medical seller in Q3 2019 was Millennium Management, an estimated $67K sold.
Based on aggregated 13F filings for Q3 2019.